Abstract
(BJOG. 2016;123(7):1107–1114) Preterm birth is associated with an increased risk of perinatal morbidity and mortality, with the earlier the birth the greater the risk. Some of the complications resulting from preterm delivery lead to impairments with long-term consequences. Hence delivery postponement through tocolytic drug use is a management goal when women develop preterm delivery. Short-term tocolysis of 48 hours to allow administration of antenatal steroids has been found to be effective. However, several studies have shown that maintenance tocolysis beyond 48 hours does not significantly prolong pregnancy. The Assessment of Perinatal Outcome with Sustained Tocolysis in Early Labour (APOSTEL II) trial assessed maintenance tocolysis with nifedipine. This current follow-up study of APOSTEL II aimed to assess the effect of nifedipine maintenance tocolysis on neurodevelopment, as measured in 2-year-old infants whose mothers participated in the study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
